Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Coronary Sinus Reducer for Angina Without Blocked Arteries

Official title: Coronary Sinus Reducer in Patients With Angina With no Obstructive Coronary Disease: a Prospective Single-arm Study

Run by Medical University of Warsaw · NCT07010029 · Data updated 2026-11-12

This trial tests whether placing a coronary sinus reducer device can relieve angina in people who have chest pain but no significant coronary artery blockages and confirmed microvascular dysfunction.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorMedical University of Warsaw
Academic / other
Locations1 site (Warsaw)
StatusRecruiting
StartedMay 12, 2025
Main results expectedMay 2027
Study endsAugust 2027
Registry record updatedJune 8, 2025
Trial IDNCT07010029 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with stable angina, no significant coronary artery stenosis, invasive-confirmed coronary microvascular dysfunction (CFR ≤ 2.5 or IMR ≥ 25), and persistent symptoms despite maximal antianginal therapy for at least three months.

Probably not a fit

Patients with vasospastic angina, severe valvular disease, significant heart failure (EF ≤ 30%), recent acute coronary events, permanent right-sided pacing/defibrillator leads, or other listed exclusions are unlikely to benefit from this device.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial implants a coronary sinus reducer to narrow the coronary sinus and raise venous pressure in the heart, aiming to alter myocardial perfusion for symptom relief. Participants must have stable angina without significant epicardial stenosis and invasive confirmation of coronary microvascular dysfunction (CFR ≤ 2.5 or IMR ≥ 25) after at least three months of maximal antianginal therapy. Key exclusions include vasospastic angina, significant valvular disease, severe left ventricular dysfunction (EF ≤ 30%), recent acute coronary syndrome or revascularization, and other conditions that increase procedural risk. The study will track changes in symptoms and microvascular physiological indices, building on limited observational data suggesting benefit.

Why it matters

Potential benefit: If successful, the device could reduce angina symptoms and improve quality of life for patients with microvascular angina who have no options left from medications.

How similar studies have gone: Observational studies and prior use of the coronary sinus reducer in patients with obstructive coronary disease have reported symptomatic improvement, but randomized evidence in microvascular angina is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Stable angina symptoms without significant obstruction of coronary artery (defined as coronary artery stenosis diameter ≤ 50% or coronary artery stenosis diameter \>50% and ≤70% with FFR\>0.8), with coronary microvascular dysfunction confirmed in invasive test (defined as coronary flow reserve ≤ 2.5 or index of microvascular resistance ≥ 25)
* No future options for antianginal therapy (maximum antianginal therapy for at least three months)

Exclusion Criteria:

* Vasospastic angina (positive test with acetylcholine),
* Evidence of cardiac ischemia,
* Coronary flow limiting myocardial bridge,
* Severe valvular disease
* Hospitalization for acute heart failure \< 3 months
* Hypertrophic cardiomyopathy,
* Ejection fraction ≤ 30%,
* Permanent pacemaker or defibrillator leads in the right heart,
* Recent acute coronary syndrome \< 6 months,
* Recent revascularization \< 2 months,
* Right atrial pressure of 15 mmHg or higher,
* Severe renal impairment,
* Indication for cardiac resynchronization therapy,
* Pregnancy,
* Life expectancy of less than 1 year,
* Inclusion in another clinical trial

Where it's running

  • Medical University of Warsaw
    Warsaw, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.